Bilcare Ltd. (BSE: 526853) is a Pune, Maharashtra-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹194 Cr, it ranks #2,679 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 10 in Life Sciences Tools and Services. At ₹82.00 (as of 19 Nov 2026), the share price is 27.4% below its 52-week high of ₹113.00 and 16.1% above its 52-week low of ₹70.60.
| Current Price | ₹82.00 |
|---|---|
| Market Cap | ₹194 Cr |
| BSE Code | 526853 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 108.3 |
| Return on Equity | -5.21% |
| Return on Assets | 1.76% |
| 52-Week Range | ₹70.60 – ₹113.00 |
| 3-Month Price Change | -12.3% |
| Beta (1Y) | 1.04 |
| Dividend Yield | 0.00% |
| Headquarters | Pune, Maharashtra |
| Website | www.bilcare-group.com |
Delivery averaged 100.0% of traded volume across 16 BSE sessions (26 Oct 2026 – 19 Nov 2026).
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.
1. Pharma Packaging Research Solutions-This segment provides pharma packaging research solutions.
1. Pharma Packaging Research Solutions & Its Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Indegene Ltd | ₹14,840 Cr | 40.2 | 13.94% | ₹1,122 Cr | +26.1% |
| Suven Life Sciences Ltd. | ₹7,951 Cr | n/m | -78.80% | ₹1 Cr | +51.8% |
| Vimta Labs Ltd | ₹2,259 Cr | 29.5 | 18.55% | ₹112 Cr | -26.8% |
| Tarsons Products Limited | ₹1,730 Cr | 114.9 | 2.26% | ₹124 Cr | +25.7% |
| Brooks Laboratories Ltd. | ₹198 Cr | 7.9 | 22.28% | ₹19 Cr | -34.2% |
| Bilcare Ltd. | ₹194 Cr | 108.3 | -5.21% | — | — |
| Jeevan Scientific Technology Ltd | ₹176 Cr | 129.4 | 1.68% | — | +42.3% |
| Vivo Bio Tech Ltd. | ₹37 Cr | n/m | -2.00% | ₹14 Cr | -55.7% |
| Dr. Habeebbullal Life Sciences Ltd | ₹26 Cr | n/m | -68.79% | — | -45.3% |
Listed by market capitalisation. Ratios are shown for context only.
Bilcare Ltd. is trading at ₹82.00, with a market capitalisation of ₹194 Cr.
Bilcare Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Bilcare Ltd. has a P/E of 108.3 and a return on equity of -5.21%.
Bilcare Ltd. is listed on the BSE under the scrip code 526853.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.